Research Points to Translational Path Toward Precision Immunotherapies for EGFR-Mutant NSCLC

Wu-Kong28 Data Support Sunvozertinib as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says

… as First-Line Treatment Option for EGFR-Mutant NSCLC, Researcher Says … Haleigh Behrman …

Combining SABR with Immunotherapy to Improve Outcomes in Early-Stage NSCLC

… with an early-stage non-small-cell lung cancer (NSCLC), research combining prospective and propensity-matched data has … microenvironment and systemic immune responses. 8  Recent research has focused on specific immune cell subsets, such as … with SABR. Substantial clinical and translational research is essential to establish the true effectiveness and …

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

… weight gain represents a promising avenue for further research. The successful combination of a GLP-1-RA and a TKI … treatment strategy. A new prospective cohort study by our research group specifically addresses this issue in patients …

Keynote Address Explores the Future of Biomarkers in the ADC Era

… R. Hirsch outlined the current state of knowledge in ADC research, as well as what still needs to be learned. … Keynote …

Arrhythmias after Radiotherapy—What Do (and Don’t) We Know?

… Researchers examine emerging data demonstrating that …

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions